SNBL to Acquire Satsuma Pharmaceuticals
Transaction delivers immediate value and liquidity to Satsuma stockholders SNBL to acquire all outstanding shares of Satsuma for upfront cash...
Source: globenewswire.com
Page 3 - Nasdaq Stsa News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq Stsa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Stsa Today - Breaking & Trending Today
Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA) Short Interest Update
Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA – Get Rating) was the recipient of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling 159,400 shares, a decrease of 40.4% from the March 15th total of 267,500 shares. Based on an average trading volume of 152,700 shares, the […]
Source: themarketsdaily.com
Satsuma Pharmaceuticals' (STSA) "Neutral" Rating Reaffirmed at Mizuho
Satsuma Pharmaceuticals (NASDAQ:STSA – Get Rating)‘s stock had its “neutral” rating reaffirmed by stock analysts at Mizuho in a research note issued on Thursday, Benzinga reports. They presently have a $2.00 price target on the financial services provider’s stock. Mizuho’s price target indicates a potential upside of 180.62% from the stock’s previous close. Satsuma Pharmaceuticals […]
Source: wkrb13.com
Satsuma Pharmaceuticals Hosting Key Opinion Leader Webinar
Thursday, June 16th @ 10:30 a.m. ET...
Source: globenewswire.com
Satsuma Pharmaceuticals (NASDAQ:STSA) Stock Crosses Above 200-Day Moving Average of $0.00
Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA – Get Rating) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $4.17. Satsuma Pharmaceuticals shares last traded at $3.86, with a volume of 57,425 shares changing hands. STSA has been the topic of several […]
Source: etfdailynews.com